EphA2 targeting CAR T cells effectively eliminate differentiated GBM cells and GBM cancer stem-like cells in vitro, and significantly prolong survival of orthotopic xenograft SCID mouse models (Chow et al., 2013). The gene discussed is EPHA2; the disease is glioblastoma.